Ausgewählte Publikationen

Engl C, Tiemann L, Grahl S, Bussas M, Schmidt P, Pongratz V, Berthele A, Beer A, Gaser C, Kirschke JS, Zimmer C, Hemmer B, Mühlau M. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy. J Neurol. 2020 Aug;267(8):2307-2318. doi: 10.1007/s00415-020-09841-0..

Grahl S, Bussas M, Pongratz V, Kirschke JS, Zimmer C, Berthele A, Hemmer B, Mühlau M. T1-Weighted Intensity Increase After a Single Administration of a Linear Gadolinium-Based Contrast Agent in Multiple Sclerosis. Clin Neuroradiol. 2020 Feb 13. doi: 10.1007/s00062-020-00882-6.

Eichinger P, Schön S, Pongratz V, Wiestler H, Zhang H, Bussas M, Hoshi MM, Kirschke J, Berthele A, Zimmer C, Hemmer B, Mühlau M, Wiestler B. Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis. Radiology. 2019 Mar 12:181568. doi: 10.1148/radiol.2019181568.

Eichinger P, Hock A, Schön S, Preibisch C, Kirschke JS, Mühlau M, Zimmer C, Wiestler B. Acceleration of Double Inversion Recovery Sequences in Multiple Sclerosis With Compressed Sensing. Invest Radiol. 2019 Jan 31. doi: 10.1097/RLI.0000000000000550.

Zhang H, Alberts E, Pongratz V, Mühlau M, Zimmer C, Wiestler B, Eichinger P. Predicting conversion from clinically isolated syndrome to multiple sclerosis-An imaging-based machine learning approach. Neuroimage Clin. 2019;21:101593. doi: 10.1016/j.nicl.2018.11.003.

Grahl S, Pongratz V, Schmidt P, Engl C, Bussas M, Radetz A, Gonzalez-Escamilla G, Groppa S, Zipp F, Lukas C, Kirschke J, Zimmer C, Hoshi M, Berthele A, Hemmer B, Mühlau M. Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis. Mult Scler Relat Disord. 2019 Apr;29:124-129. doi: 10.1016

Riederer I, Mühlau M, Hoshi MM, Zimmer C, Kleine JF. Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials. J Neurol. 2019 Jan;266(1):148-156. doi: 10.1007

Feucht N, Maier M, Lepennetier G, Pettenkofer M, Wetzlmair C, Daltrozzo T, Scherm P, Zimmer C, Hoshi MM, Hemmer B, Korn T, Knier B. Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis. Mult Scler. 2019 Feb;25(2):224-234. doi: 10.1177

Righart R, Biberacher V, Jonkman LE, Klaver R, Schmidt P, Buck D, Berthele A, Kirschke JS, Zimmer C, Hemmer B, Geurts JJG, Mühlau M. Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging. Ann Neurol. 2017 Oct;82(4):519-529. doi: 10.1002/ana.25020. Epub 2017 Sep 16. PMID: 28833433

Eichinger P, Wiestler H, Zhang H, Biberacher V, Kirschke JS, Zimmer C, Mühlau M, Wiestler B. A novel imaging technique for better detecting new lesions in multiple sclerosis. J Neurol. 2017 Jul 29.

Eichinger P, Kirschke JS, Hoshi MM, Zimmer C, Mühlau M, Riederer I. Pre- and Postcontrast 3D Double Inversion Recovery Sequence in Multiple Sclerosis: A Simple and Effective MR Imaging Protocol. AJNR Am J Neuroradiol. 2017

Righart R, Schmidt P, Dahnke R, Biberacher V, Beer A, Buck D, Hemmer B, Kirschke JS, Zimmer C, Gaser C, Mühlau M. Volume versus surface-based cortical thickness measurements: A comparative study with healthy controls and multiple sclerosis patients. PLoS One. 2017 Jul 6;12(7)

Biberacher V, Schmidt P, Selter RC, Pernpeinter V, Kowarik MC, Knier B, Buck D, Hoshi MM, Korn T, Berthele A, Kirschke JS, Zimmer C, Hemmer B, Mühlau M. Fatigue in multiple sclerosis: Associations with clinical, MRI and CSF parameters. Mult Scler. 2018 Jul;24(8):1115-1125. doi: 10.1177

Marschallinger R, Mühlau M, Pongratz V, Kirschke JS, Marschallinger S, Schmidt P, Sellner J. Geostatistical Analysis of White Matter Lesions in Multiple Sclerosis Identifies Gender Differences in Lesion Evolution. Front Mol Neurosci. 2018 Dec 17;11:460. doi: 10.3389/

Graetz C, Gröger A, Luessi F, Salmen A, Zöller D, Schultz J, Siller N, Fleischer V, Bellenberg B, Berthele A, Biberacher V, Havla J, Hecker M, Hohlfeld R, Infante-Duarte C, Kirschke JS, Kümpfel T, Linker R, Paul F, Pfeuffer S, Sämann P, Toenges G, Weber F, Zettl UK, Jahn-Eimermacher A, Antony G, Groppa S, Wiendl H, Hemmer B, Mühlau M, Lukas C, Gold R, Lill CM, Zipp F. Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis. Mult Scler. 2018 Mar 1:1352458518763541. doi: 10.1177/1352458518763541

Knier B, Leppenetier G, Wetzlmair C, Aly L, Hoshi MM, Pernpeintner V, Biberacher V, Berthele A, Mühlau M, Zimmer C, Hemmer B, Korn T. Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis. JAMA Neurol. 2017 Jul 1;74(7):847-856.

Knier B, Schmidt P, Aly L, Buck D, Berthele A, Mühlau M, Zimmer C, Hemmer B, Korn T. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain. 2016 Aug 30

Biberacher V, Schmidt P, Keshavan A, Boucard CC, Righart R, Sämann P, Preibisch C, Fröbel D, Aly L, Hemmer B, Zimmer C, Henry RG, Mühlau M. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis. Neuroimage. 2016 Jul 16

Beer A, Biberacher V, Schmidt P, Righart R, Buck D, Berthele A, Kirschke J, Zimmer C, Hemmer B, Mühlau M. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity. J Neurol. 2016 Aug;263(8):1495-502.

Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA, Harbo HF, Hemmer B, Jordan K, Kappos L, Kirkish G, Llufriu S, Magon S, Martinelli-Boneschi F, McCauley JL, Montalban X, Mühlau M, Pelletier D, Pattany PM, Pericak-Vance M, Cournu-Rebeix I, Rocca MA, Rovira A, Schlaeger R, Saiz A, Sprenger T, Stecco A, Uitdehaag BM, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F; International Multiple Sclerosis Genetics Consortium. Electronic address: AIVINSON@PARTNERS.ORG., Hauser SL, Oksenberg JR, Henry RG. Power estimation for non-standardized multisite studies. Neuroimage. 2016 Jul 1;134:281-94.

Biberacher V, Boucard CC, Schmidt P, Engl C, Buck D, Berthele A, Hoshi MM, Zimmer C, Hemmer B, Mühlau M. Atrophy and structural variability of the upper cervical cord in early multiple sclerosis. Mult Scler. 2015 Jun;21(7):875-84.

Knier B, Berthele A, Buck D, Schmidt P, Zimmer C, Mühlau M, Hemmer B, Korn T. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler. 2015 Sep

Marschallinger R, Schmidt P, Hofmann P, Zimmer C, Atkinson PM, Sellner J, Trinka E, Mühlau M. A MS-lesion pattern discrimination plot based on geostatistics. Brain Behav. 2016 Jan 30;6(3):e00430.

Riederer I, Karampinos D C, Settles M, Preibisch C, Bauer J S, Kleine J, Mühlau M, Zimmer, C. Double. Inversion Recovery (DIR) sequence of the cervical spinal cord in multiple sclerosis (MS) and related inflammatory diseases AJNR 2015 Jan;36(1):219-25.

Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. Mult Scler. 2013 Oct;19(11):1485-92.

Schmidt P, Gaser C, Arsic M, Buck D, Förschler A, Berthele A, Hoshi M, Ilg R, Schmid VJ, Zimmer C, Hemmer B, Mühlau M. An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis. Neuroimage. 2012 Feb 15;59(4):3774-83